EPCAM and colorectal cancer: We here show that such mutated colorectal cancer cells are highly sensitive to lysis by an EpCAM-specific T cell-engaging antibody, suggesting that redirected lysis by T cells is not affected by mutations in intracellular signaling proteins of the EGFR pathway.